netFormulary
 Report : A-Z HCD items in Formulary 27/09/2023 13:11:19
[Back]
 
Section Status BlueTeq Name
08.03.04.01 Formulary BlueTeq Abemaciclib Verzenios
08.01.05 Formulary BlueTeq Acalabrutinib Calquence
08.01.05 Formulary BlueTeq Alectinib Alecensa
08.03.04.01 Formulary BlueTeq Alpelisib Piqray
08.03.04.02 Formulary BlueTeq Apalutamide  Erleada
08.01.05 Formulary BlueTeq Asciminib Scemblix
08.01.05 Formulary BlueTeq Atezolizumab 
03.04.02 Formulary BlueTeq Benralizumab Fasenra
08.01.05 Formulary BlueTeq Brigatinib Alunbrig
08.01.05 Formulary BlueTeq Carfilzomib Kyprolis
08.01.05 Formulary BlueTeq Cemiplimab Libtayo
08.01.05 Formulary BlueTeq Crizanlizumab Adakveo
08.01.05 Formulary BlueTeq Dacomitinib Vizimpro
08.01.05 Formulary BlueTeq Daratumumab Darzalex
08.01.05 Formulary BlueTeq Dinutuximab beta Qarziba
08.02.04 Formulary BlueTeq Diroximel fumarate Vumerity
03.04.02 Formulary BlueTeq Dupilumab Dupixent
08.01.05 Formulary BlueTeq Entrectinib Rozlytrek
05.03.01 Formulary BlueTeq Fostemsavir Rukobia
08.01.05 Formulary BlueTeq Gemtuzumab ozogamicin Mylotarg
08.01.05 Formulary BlueTeq Gilteritinib Xospata
08.01.05 Formulary BlueTeq Idelalisib  
08.01.05 Formulary BlueTeq Inotuzumab ozogamicin Besponsa
08.01.05 Formulary BlueTeq Ipilimumab Yervoy
08.01.05 Formulary BlueTeq Lorlatinib Lorviqua
03.04.02 Formulary BlueTeq Mepolizumab Nucala
10.02 Formulary BlueTeq Mexiletine Namuscla
08.01.05 Formulary BlueTeq Midostaurin Rydapt
08.01.05 Formulary BlueTeq Mogamulizumab  Poteligeo
08.01.05 Formulary BlueTeq Neratinib Nerlynx
08.01.05 Formulary BlueTeq Niraparib Zejula
08.01.05 Formulary BlueTeq Nivolumab  Opdivo
08.02.03 Formulary BlueTeq Ocrelizumab Ocrevus
08.02.03 Formulary BlueTeq Ofatumumab  Kesimpta
08.01.05 Formulary BlueTeq Olaparib  
03.04.02 Formulary BlueTeq Omalizumab 
08.01.05 Formulary BlueTeq Panobinostat  
08.01.05 Formulary BlueTeq Pembrolizumab  Keytruda
08.01.05 Formulary BlueTeq Pertuzumab Perjeta
08.01.05 Formulary BlueTeq Polatuzumab vedotin Polivy
08.02.04 Formulary BlueTeq Ponesimod Ponvory
08.01.05 Formulary BlueTeq Regorafenib Stivarga
03.04.02 Formulary BlueTeq Reslizumab Cinquil
08.01.05 Formulary BlueTeq Selumetinib Koselugo
08.02.04 Formulary BlueTeq Siponimod Mayzent
10.01.03 Formulary BlueTeq Tocilizumab RoActemra
08.01.05 Formulary BlueTeq Venetoclax Venclyxto
North East and North Cumbria